Premenstrual dysphoric disorder: brief review

Authors

  • Renata Demarque Psiquiatra do Programa de Saúde Mental da Mulher (ProMulher) do Instituto de Psiquiatria do Hospital das Clínicas da Universidade de São Paulo (USP), São Paulo.
  • Joel Rennó Jr Médico Psiquiatra. Diretor do Programa de Saúde Mental da Mulher (ProMulher) do Instituto de Psiquiatria do Hospital das Clínicas da Universidade de São Paulo (USP), São Paulo. Doutor em Psiquiatria pela FMUSP. Membro fundador da International Association for Women’s Mental Health. Médico do Corpo Clínico do Hospital Israelita Albert Einstein – SP. https://orcid.org/0000-0003-1954-5898
  • Hewdy Lobo Ribeiro Psiquiatra Forense, Psicogeriatra e Psicoterapeuta pela Associação Brasileira de Psiquiatria. Psiquiatra do ProMulher do Instituto de Psiquiatria da USP.
  • Juliana Pires Cavalsan Psiquiatra do Programa de Saúde Mental da Mulher (ProMulher) do Instituto de Psiquiatria do Hospital das Clínicas da Universidade de São Paulo (USP), São Paulo.
  • Renan Rocha Médico Psiquiatra. Coordenador do Serviço de Saúde Mental da Mulher das Clínicas Integradas da Universidade do Extremo Sul Catarinense (UNESC).
  • Amaury Cantilino Diretor do Programa de Saúde Mental da Mulher da Universidade Federal de Pernambuco (UFPE). Professor Adjunto do Departamento de Neuropsiquiatria da UFPE.
  • Jerônimo de Almeida M. Ribeiro Médico Psiquiatra. Especialista em Psiquiatria pela Associação Brasileira de Psiquiatria. Pesquisador do Grupo de Psiquiatria – Transtornos Relacionados ao Puerpério, pela Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA). Professor Associado do Centro de Estudos José de Barros Falcão (CEJBF).
  • Gislene Valadares Médica Psiquiatra pela Associação Brasileira de Psiquiatria. Mestre em Farmacologia e Bioquímica Molecular. Membro fundador do Serviço de Saúde Mental da Mulher do HC-UFMG, do Ambulatório de Acolhimento e Tratamento de Famílias Incestuosas (AMEFI, HC-UFMG), da Seção de Saúde Mental da Mulher da WPA e da International Association of Women’s Mental Health.
  • Antonio Geraldo da Silva Psiquiatra. Especialista em Psiquiatria e Psiquiatria Forense pela ABP-AMB-CFM. Doutoramento em Bioética pela Universidade do Porto – CFM. Psiquiatra da Secretaria de Saúde do Distrito Federal – SES-DF. Diretor Científico do PROPSIQ. Presidente da ABP-2010/2013. https://orcid.org/0000-0003-3423-7076

DOI:

https://doi.org/10.25118/2763-9037.2013.v3.379

Keywords:

premenstrual dysphoric disorder, serotonin, pathophysiology

Abstract

While most women of reproductive age suffer from some degree of premenstrual symptoms, usually involving mood changes and
somatic complains, only a small percentage have the more severe form, known as premenstrual dysphoric disorder, which causes
marked impairment in the patients life and in the life of her family. This paper will help the clinician to recognize, understand and
treat this disorder

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

• 1. Epperson CN. Premenstrual Dysphoric Disorder and the Brain. Am J Psychiatry. March 2013; 170: 248-252. DOI: https://doi.org/10.1176/appi.ajp.2012.12121555

• 2. Vigod SN, Frey BN, Soares CN, Steiner M. Approach to Premenstrual Dysphoria for the Mental Health Practitioner. Psychiatr Clin North Am. 2010; 33: 257-72. DOI: https://doi.org/10.1016/j.psc.2010.01.008

• 3. Carvalho VCP, Cantilino A, Carreiro NMP, Sá LF, Sougey EB. Repercussões do transtorno disfórico pré-menstrual entre universitárias. Rev. Psiquiatr RS. 2009; 31 : 105-111. DOI: https://doi.org/10.1590/S0101-81082009000200004

• 4. Baller EB, Wei SM, Kohn PD, Rubinow DR, Alarcon G, Schmidt PJ, Berman KF. Abnormalities of dorsolateral prefrontal function in women with premenstrual dysphoric disorder: a multimodal neuroimaging study. AM J Psychiatry, 2013; 170:305-314. DOI: https://doi.org/10.1176/appi.ajp.2012.12030385

• 5. Diegoli M S C, Demarque R, Bogar M.Transtorno Disfórico Pré-Menstrual: Abordagem Conjunta da Ginecologia e Psiquiatria, em: Rennó Jr J, Ribeiro H L. Tratado de saúde mental da mulher. São Paulo, Atheneu, 2012, 163-174.

• 6. Epperson CN, Steiner M, Hartlage AS, Eriksson E, Schmidt PJ, Jones I, Yonkers KA. Premenstrual Dysphoric Disorder Evidence for a New Category for DSM V. Am J Psychiatry 2012; 169:465-475. DOI: https://doi.org/10.1176/appi.ajp.2012.11081302

• 7. Valadares GC, Ferreira LV, Correa Filho H, Romano-Siva MA. Transtorno disfórico pré-menstrual revisão – conceito, história, epidemiologia e etiologia. Rev. Psiq. Clín. 2006; 33: 117-123. DOI: https://doi.org/10.1590/S0101-60832006000300001

• 8. CarvalhoVCP, Cantilino A, Gonçalves CRK, Moura RT, Sougey EB. Prevalência da síndrome de tensão pré-menstrual e do transtorno disfórico pré-menstrual entre estudantes universitárias. Neurobiologia. 2010; 73: 41-59.

• 9. Kaur G, Gonsalves L, Thacker HL. Premenstrual dysphoric disorder: A review for the treating practitioner. Cleveland Clinic Journal of Medicine 2004; 71: 303-21. DOI: https://doi.org/10.3949/ccjm.71.4.303

• 10. Pearlstein T, Steiner M. Premenstrual dysphoric disorder: burden of illness and treatment update. J Psychiatry Neurosci. 2008; 33: 291-301. DOI: https://doi.org/10.1002/9780470515167.ch68

• 11. Brilhante AVM, Bilhar APM, Carvalho CB, Karbage SAL, Pequeno Filho EP, Rocha ES. Femina. 2010; 38: 373-78.

• 12. Teng CT, Vieira Filho AHG, Artes R, Gorenstein C, Andrade LH, Wang YP. Premenstrual dysphoric symptoms amongst Brazilian college students: factor struture and methodological appraisal. Eur Arch Psychiatry Clin Neurosci 2005; 255: 51-56. DOI: https://doi.org/10.1007/s00406-004-0535-9

• 13. Rennó Jr J, Demarque R. Transtorno Disfórico Pré-Menstrual, em: Urbanetz AA, Luz SH. Programa de Atualização em Ginecologia e Obstetrícia. 2012;9: 35-55.

• 14. Inoue Y, Terao T, Iwata N, Okamoto K, Kojima H, Okamoto T, et al. Fluctuating serotonergic function in premenstrual dysphoric disorder and premenstrual syndrome: findings from neuroendocrine challenge tests. Psychopharmacology, 2007;190: 213–9. DOI: https://doi.org/10.1007/s00213-006-0607-9

• 15. Rapkin AJ, Akopians Al. Pathophysyology of premenstrual syndrome and premenstrual dysphoric disorder. Menopause International. 2012; 18:52-59. DOI: https://doi.org/10.1258/mi.2012.012014

• 16. Halbreich U. The etiology, biology, and evolving pathology of premenstrual syndromes.Psychoneuroendocrinology. 2003;28 :55-99. DOI: https://doi.org/10.1016/S0306-4530(03)00097-0

• 17. Young SA, Hurt PH, Benedek DM, Howard RS. Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomized, double-blind, placebo-controlled crossover trial. J Clin Psychiatry. 1998. 59:76-80. DOI: https://doi.org/10.4088/JCP.v59n0206

• 18. Steiner M, Dunn EJ, MacDougall M, et al. Serotonin transporter gene polymorphism, free testosterone, and symptoms associated with premenstrual dysphoric disorder. Biol Psychiatry.2002;51-91S.

• 19. Berman SM, London ED, Morgan M, Rapkin AJ. Elevated gray matter volume of the emotional cerebellum in women with premenstrual dysphoric disorder. Journal of Affective Disorders. 2013; 146:266-271. DOI: https://doi.org/10.1016/j.jad.2012.06.038

• 20. Huo L, Straub RE, Schmidt PJ, et al. Risk for premenstrual dysphoric disorder Is associated with genetic variation in ESR1, the estrogen receptor alpha gene. Biol Psychiatry. 2007,62:925-33. DOI: https://doi.org/10.1016/j.biopsych.2006.12.019

• 21. Lustyk MKB, Gerrish WG, Shaver S, Keys SL. Cognitive behavioral therapy for premenstrual syndrome and premenstrual dysphoric disorder: A systematic review. Arch Womens Ment Healh. February. 2009; 12:85-96. DOI: https://doi.org/10.1007/s00737-009-0052-y

• 22. Choung CJ, Dawson EB. Critical evalution of nutricional factors in the pathophysiology and treatment of premenstrual syndrome. Clin Obstet Gynecol. 1992.35:679-92. DOI: https://doi.org/10.1097/00003081-199209000-00026

Downloads

Published

2013-04-30

How to Cite

1.
Demarque R, Rennó Jr J, Ribeiro HL, Cavalsan JP, Rocha R, Cantilino A, et al. Premenstrual dysphoric disorder: brief review. Debates em Psiquiatria [Internet]. 2013 Apr. 30 [cited 2025 May 9];3(5):6-11. Available from: https://revistardp.org.br/revista/article/view/379

Conference Proceedings Volume

Vol. 3 No. 5 (2013)

Section

Review Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Debates em Psiquiatria allows the author (s) to keep their copyrights unrestricted. Allows the author (s) to retain their publication rights without restriction. Authors should ensure that the article is an original work without fabrication, fraud or plagiarism; does not infringe any copyright or right of ownership of any third party. Authors should also ensure that each one complies with the authorship requirements as recommended by the ICMJE and understand that if the article or part of it is flawed or fraudulent, each author shares responsibility.

Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) - Debates em Psiquiatria is governed by the licencse CC-By-NC
You are free to:

  • Share — copy and redistribute the material in any medium or format
  • Adapt — remix, transform, and build upon the material

The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.

No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Crossref
Scopus
Google Scholar
Europe PMC

Plaudit